Professor Hefeng Huang received her MD degree from Zhejiang University, School of Medicine in 1982, and additional trainings from the University of Hong Kong in 1992 and the University of Cincinnati in 1998. Professor Huang began her career as a professor of medicine in Zhejiang University and Shanghai Jiaotong University, and she currently resides as a Professor of Medicine and the President of The Institute of Reproduction and Development at Shanghai Fudan University. She also holds a guest professorship at the University of Adelaide, Australia, and the University of Hongkong. As an academic leader, Professor Huang has led many state-funded research programs, including the “973 Science Projects”, the 12th “Five-Year-Plan” in Science and Technology, “863 Research Projects”, and the Center for Basic Research of the Chinese Lab in Embryonic Origin of Health and Disease, sponsored by the Shanghai Municipal Government.
As an obstetrician/gynecologist, Professor Huang has been actively conducting basic, clinical, and translation research for the past thirty years. Her lab research focuses on common problems that affect women’s reproductive health, including infertility, PCOS, gestational diabetes mellitus (GDM), etc. She was among the experts who first proposed the concept, which was later termed Developmental Origin of Health and Disease (DoHaD). Her lab was the first to discover a novel mechanism underlying oocyte-mediated intergenerational transmission of an acquired epigenetic phenotype: disruptions of the paternal genome during post-fertilization reprogramming due to insufficiency of the maternal factor, TET3 (Nature, 2022, 605:761). This discovery further proofs the concepts on the gamete origins of adult diseases, which was also first introduced by Professor Huang. Her team was also the first to provide solid experimental evidence showing that despite insulin therapy on mothers with GDM, their offspring remain susceptible to metabolic disorders, especially when exposed to adverse postnatal environments (Diabetes, 2012, 61:1133; 2014, 63:2906; 2019, 68:696). And it was her lab who first demonstrated a previously unsuspected etiology of PCOS. i.e., alternative splicing of AR in GCs can alter the expression of genes related to androgen metabolism and folliculogenesis, thereby resulting in hyperandrogenism and abnormalities in folliculogenesis (PNAS, 2015, 112:4743). Professor Huang and her team has published over 320 papers on such topics in reputable journals and has been a dedicated contributor in the advancement of women’s reproductive health.
In recognition of her contributions to human reproductive science, Professor Huang was elected as an Academician to the Chinese National Academy of Science in 2017. She was also elected as a Fellow Honoris Causa of the Royal College of Obstetricians and Gynecologists of the UK in 2017, a member of the World Academy of Sciences in 2018, and a member of the Chinese Academy of Medical Sciences in 2019. She has received many academic rewards, including the National Award for the Advancement of Science and Technology in 2021, the highest honor bestowed upon researchers and scientists in China.